Table 1.
Damage score | Extension of necrosis (cm) | Colonic weight/length ratio (mg cm−1) | |||||||
---|---|---|---|---|---|---|---|---|---|
1 (week) | 2 (week) | 1 (week) | 2 (week) | 1 (week) | 2 (week) | ||||
Control | 0 (0–0) | 0 | 69.1±3.5 | ||||||
TNBS | 5 (5–6) | 4 (3–4) | 2.3±0.2 | 0.8±0.1 | 170.2±13.4+ | 92.3±3.9+ | |||
Diosmectite | 5 (1.8–5)* | 3 (2–4) | 1.0±0.2* | 0.7±0.2 | 119.0±9.9+* | 94.8±6.0+ | |||
Sulphasalazine | 4 (4–6) | 4 (2–4) | 1.5±0.3 | 0.7±0.2 | 154.0±9.6+ | 83.8±4.9+ |
Results are expressed as median (25–75% quartiles) and mean±s.e.m., respectively.
P<0.05 compared with TNBS group. Groups TNBS, diosmectite and sulphasalazine were significantly different from the control group at all time points (not shown).